Outcome after local recurrence of osteosarcoma - The St. Jude Children's Research Hospital experience (1970-2000)

被引:56
作者
Rodriguez-Galindo, C
Shah, N
McCarville, MB
Billups, CA
Neel, MN
Rao, BN
Daw, NC
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA
[3] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA
关键词
osteosarcoma; local recurrence; children; limb-sparing;
D O I
10.1002/cncr.20214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Despite improvements in therapy for osteosarcoma, approximately 4-10% of patients experience a local recurrence and have a poor prognosis. METHODS. The authors analyzed prognostic factors for survival in 26 patients with a local recurrence of osteosarcoma who were treated between 1970 and 2000. RESULTS. The initial surgical procedure was amputation in 20 patients (76.9%) and limb salvage in 6 patients (23.1%). The median time from the diagnosis of osteosarcoma to local recurrence was 1.2 years (range, 1.2 months-6.1 years). Eleven patients (42.3%) developed an isolated local recurrence and 15 patients (57.7%) developed local and distant recurrence. The 5-year estimate of postrecurrence survival (PRS) (+/- 1 standard error) for the 26 patients was 19.2% +/- 7.7%. Recurrence greater than or equal to 2 years from the time of diagnosis was found to predict a better outcome (5-year PRS of 50.0% +/- 20.4%) compared with earlier recurrence (10.0% +/- 5.5%) (P = 0.037). Patients with negative margins after initial surgery were found to have improved survival (5-year PRS of 33.3% +/- 13.6%) compared with patients with positive margins (7.1% +/- 4.9%) (P = 0.015). Patients who underwent complete surgical resection at the time of recurrence were found to have a better PRS (5-year PRS of 41.7% +/- 14.2%) compared with patients who did not undergo surgery (0% +/- 0%) (P < 0.001). CONCLUSIONS. The prognosis for patients after local recurrence of osteosarcoma is poor. Complete surgical resection at the time of recurrence is essential for survival. Positive margins at the time of initial surgical resection and early recurrence appear to be poor prognostic factors.
引用
收藏
页码:1928 / 1935
页数:8
相关论文
共 38 条
[1]   Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Longhi, A ;
Perin, S ;
Forni, C ;
Fabbri, N ;
Salduca, N ;
Versari, M ;
Smith, KVJ .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) :32-38
[2]   Predictive factors for local recurrence in osteosarcoma - 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Mercuri, M ;
Bertoni, F ;
Picci, P ;
Manfrini, M ;
Gasbarrini, A ;
Forni, C ;
Cesari, M ;
Campanacci, M .
ACTA ORTHOPAEDICA SCANDINAVICA, 1998, 69 (03) :230-236
[3]   A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity [J].
Bacci, G ;
Ferrari, S ;
Tienghi, A ;
Bertoni, F ;
Mercuri, M ;
Longhi, A ;
Fiorentini, G ;
Forni, C ;
Bacchini, P ;
Rimondini, S ;
De Giorgi, U ;
Picci, P .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (01) :98-104
[4]   Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli Osteosarcoma-2 protocol: An updated report [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Ruggieri, P ;
Picci, P ;
Longhi, A ;
Casadei, R ;
Fabbri, N ;
Forni, C ;
Versari, M ;
Campanacci, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) :4016-4027
[5]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[6]   Surgical procedure and local recurrence in 223 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols -: The Scandinavian Sarcoma Group experience [J].
Brosjö, O .
ACTA ORTHOPAEDICA SCANDINAVICA, 1999, 70 :58-61
[7]  
CALUSER CI, 1994, EUR J NUCL MED, V21, P1198
[8]  
Daw NC, 2000, CANCER-AM CANCER SOC, V88, P2172, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2172::AID-CNCR25>3.0.CO
[9]  
2-7
[10]   Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy [J].
Ferrari, S ;
Bacci, G ;
Picci, P ;
Mercuri, M ;
Briccoli, A ;
Pinto, D ;
Gasbarrini, A ;
Tienghi, A ;
delPrever, AB .
ANNALS OF ONCOLOGY, 1997, 8 (08) :765-771